At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Jeremy Thomas, MD, from Western General Hospital, Edinburgh, United Kingdom, discusses the results of a central pathology review, including tumour type, histological grade and lymphatic invasion, of the SUPREMO trial, a randomised, global phase 3 clinical trial evaluating radiotherapy after mastectomy for patients with intermediate-risk breast cancer.
European Medical Journal
Website: http://emjreviews.com/
Twitter: https://twitter.com/EMJReviews
Facebook: https://www.facebook.com/emjreviews
Advertisement